IP Library Granted Patent US 10,889,598
Granted Patent B2
US 10,889,598 · App. 16/193,451 · Granted Jan 12, 2021

Method to make scalable ultrathin hexagonally faceted metal-organic framework (MOF) and method of using same for detecting explosives and other nitro-aromatic compounds

Inventors: Sundaram Gunasekaran (Madison, WI); Anu Pratap Mylamparambil Udayan (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C07F3/06C07F3/003G01N27/30G01N27/4045G01N27/48B01J20/226B01J20/3085G01N33/0057G01N33/227
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,889,598
App. No.
16/193,451
Granted
Jan 12, 2021
Kind
B2
Abstract

A method to make metal-organic frameworks (MOFs) in which a first aqueous solution of a transition metal salt is mixed with a second aqueous solution of an imidazole or alkyl-substituted imidazole to yield a product solution containing MOF crystals. The MOF crystals are used to fabricate electrodes for electrochemical detection of nitro-aromatic compounds.

Claims (16)

1. A method to make metal-organic frameworks (MOFs), the method comprising mixing a first aqueous solution comprising a transition metal salt with a second aqueous solution comprising imidazole or alkyl-substituted imidazole for a time and at a temperature to yield a product solution containing MOF crystals;

wherein the first aqueous solution comprises from about 0.01 M to about 0.5 M of the transition metal salt and the second aqueous solution comprises about 1 mM to about 100 mM of the imidazole or alkyl-substituted imidazole.

2. The method of claim 1 , wherein the transition metal salt in the first aqueous solution comprises a metal selected from the group consisting of scandium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, and zinc, and an anion selected from the group consisting of nitrate, sulfate, acetate, and halide.

3. The method of claim 2 , wherein the transition metal salt in the first aqueous solution comprises zinc nitrate.

4. The method of claim 3 , wherein the second aqueous solution comprises 2-methylimidazole.

5. The method of claim 1 , wherein the second aqueous solution comprises 2-methylimidazole.

6. The method of claim 1 , comprising mixing the first aqueous solution and the second aqueous solution for a time of about 1 minute to about 10 minutes.

7. The method of claim 1 , comprising mixing the first aqueous solution and the second aqueous solution at a temperature of about 20±5°.

8. The method of claim 1 , further comprising separating the MOF crystals from the product solution.

9. The method of claim 8 , comprising separating the MOF crystals from the product solution via centrifugation.

10. The method of claim 8 , further comprising, after the MOF crystals are separated from the product solution, drying the MOF crystals.

11. The method of claim 8 , wherein the MOF crystals are air-dried at a temperature of about 40° C. to about 100° C.

12. A composition of matter which is not ZIF-8, made by mixing a first aqueous solution comprising a transition metal salt with a second aqueous solution comprising imidazole or alkyl-substituted imidazole for a time and at a temperature to yield a product solution containing MOF crystals;

wherein the first aqueous solution comprises from about 0.01 M to about 0.5 M of the transition metal salt and the second aqueous solution comprises about 1 mM to about 100 mM of the imidazole or alkyl-substituted imidazole.

13. The composition of matter of claim 12 , wherein the transition metal salt in the first aqueous solution comprises a metal selected from the group consisting of scandium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, and an anion selected from the group consisting of nitrate, sulfate, acetate, and halide.

14. The composition of matter of claim 12 , wherein the second aqueous solution comprises 2-methylimidazole.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2018
From: GUNASEKARAN, SUNDARAM; MYLAMPARAMBIL UDAYAN, ANU PRATHAP
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 047590/0835 →
Continuity (2)
Provisional Application 62589127 · Nov 21, 2017
Related Publication 20190152995A1 · May 23, 2019